# Investigational New Drugs

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/investigational-new-drugs/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 4,390 |
| Citations | 108,399 |
| h-index | 115 |
| Homepage | https://www.springer.com/journal/10637 |
| Open Access | false |
| ISSN-L | 0167-6997 |
| ISSNs | 0167-6997,1573-0646 |
| OpenAlex ID | https://openalex.org/S6037287 |
| Publisher | Springer Science+Business Media |
| Works | 4,011 |

## Journal papers

- [Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study](https://scholariq.org/papers/carbamazepine-for-prevention-of-oxaliplatin-related-neurotoxicity-in-patients/)
- [Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors](https://scholariq.org/papers/phase-i-study-of-amatuximab-a-novel-monoclonal-antibody-to-mesothelin-in/)
- [A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer](https://scholariq.org/papers/a-randomized-open-label-multicenter-phase-ii-study-evaluating-the-efficacy-and/)
- [Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers](https://scholariq.org/papers/addition-of-an-antiangiogenic-therapy-bevacizumab-to-gemcitabine-plus/)
- [Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer](https://scholariq.org/papers/efficacy-of-immune-checkpoint-blockade-in-mutyh-associated-hereditary-colorectal/)
- [The analysis of molecular classification of pulmonary neuroendocrine tumors and relationship between YAP1 and efficacy](https://scholariq.org/papers/the-analysis-of-molecular-classification-of-pulmonary-neuroendocrine-tumors-and/)

## Journal top topics

Showing 8 of 25.

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.